# Ginger Extract Standardization Gate

Date checked: 2026-06-05
Status: held-item material and endpoint gate, not treatment advice and not
contact permission

## Purpose

This gate prevents standardized 6-shogaol-rich ginger extract from entering a
lab quote as ordinary ginger, supplement language, or an HbF/cure candidate.

Current operational label:

`case001_ginger_extract_standardization_gate_hold`

## Current Read

| Layer | Result | Quote meaning |
| --- | --- | --- |
| Quran anchor | Quran 76:17 names ginger in a reward/provision context | Motivation for disciplined curiosity only, not pharmacology proof. |
| PubChem 6-shogaol | `CID 5281794`, formula `C17H24O3`, InChIKey `OQWKEEOHDMUXEO-BQYQJAHWSA-N` | Marker compound identity can be named. |
| PubChem 6-gingerol | `CID 442793`, formula `C17H26O4`, InChIKey `NLDDIKRKFXEWBK-AWEZNQCLSA-N` | Related marker/precursor context can be named. |
| Literature | PMID `40938906`, DOI `10.1371/journal.pone.0332386`, PLOS One 2025 | Evidence is ex vivo beta-thalassemia red-cell support. |
| HbF query | Focused PubMed search on ginger/Zingiber/6-shogaol/6-gingerol plus fetal hemoglobin/gamma-globin/HBG returned 0 records | Do not frame ginger as an HbF lane. |
| Registry query | ClinicalTrials.gov ginger-thalassemia and Zingiber-thalassemia checks returned no studies | No trial or clinical-intervention claim. |

## Material Requirements Before Quote

Ginger extract can move from held to quote-candidate only if the material
record has:

- extract process named, with pulsed electric field (`PEF`) or an equivalent
  process explicitly documented;
- quantified 6-shogaol and 6-gingerol content by `HPLC`, `LC-MS`, or equivalent
  method;
- batch or lot identifier;
- solvent, excipient, and vehicle records;
- storage and stability context;
- microbial, contaminant, or extract-matrix control context if available;
- vehicle control and extract-matrix control accepted by the lab.

## Support-Only Endpoint Set

Allowed readouts are mature red-cell support endpoints:

- mature red-cell hemolysis;
- oxidative hemolysis challenge if the lab supports it;
- lipid peroxidation or `TBARS`;
- red-cell membrane non-heme iron if the lab supports it;
- osmotic fragility or red-cell deformability if available;
- methemoglobin or membrane-damage context if available.

Blocked endpoint claims:

- HbF induction;
- `HBG1` or `HBG2` induction;
- transfusion reduction;
- chelation replacement;
- curative effect;
- patient supplementation.

## Decision

Keep standardized 6-shogaol-rich ginger extract out of the first quote. The
material has a thalassemia-specific ex vivo red-cell support signal, but the
extract process, marker assay, batch controls, matrix controls, and endpoint
wording are not ready enough for pricing.

## Boundary

This gate does not recommend ginger, ginger extract, supplements, dosing,
transfusion changes, chelation changes, trial screening, travel, import, or
treatment selection.

## Islamic Motivation Boundary

Quran 76:17 supports disciplined curiosity about ginger. Quran 13:17 supports
discarding weak or noisy signals. Quran 55:7-9 supports measured claims. These
are not biomedical evidence for ginger extract.

## Sources

- [June 5 workflow map](../../../data/workflows/case-001/2026-06-05-ginger-extract-standardization-gate.json)
- [Ginger shogaol red-cell support map](../findings/2026-04-27-ginger-shogaol-red-cell-support-map.md)
- [Quran 76:17 structured note](../../islamic/quran/076-al-insan/017.md)
- [PubMed PMID 40938906](https://pubmed.ncbi.nlm.nih.gov/40938906/)
- [PLOS DOI 10.1371/journal.pone.0332386](https://doi.org/10.1371/journal.pone.0332386)
- [PubChem CID 5281794](https://pubchem.ncbi.nlm.nih.gov/compound/5281794)
- [PubChem CID 442793](https://pubchem.ncbi.nlm.nih.gov/compound/442793)
- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [Quran 13:17 benefit-versus-foam anchor](../../islamic/quran/013-ar-rad/017.md)
- [Quran 55:7-9 mizan anchor](../../islamic/quran/055-ar-rahman/007-009.md)
